Aarti Drugs Limited
NSE:AARTIDRUGS.NS
490 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25,285.8 | 27,160.5 | 24,886.458 | 21,547.798 | 18,060.885 | 15,609.41 | 12,436.288 | 11,951.71 | 11,348.818 | 10,942.716 | 9,699.372 | 8,248.414 | 6,592.609 | 5,010.465 | 4,785.019 | 3,821.189 | 3,123.586 | 2,894.86 |
| Cost of Revenue
| 18,315.1 | 18,885.1 | 19,848.201 | 15,544.706 | 14,018.253 | 12,472.629 | 9,448.806 | 9,056.269 | 8,829.81 | 8,551.089 | 7,553.72 | 6,473.221 | 5,335.879 | 4,071.776 | 3,732.616 | 2,980.504 | 2,516.951 | 2,319.861 |
| Gross Profit
| 6,970.7 | 8,275.4 | 5,038.257 | 6,003.092 | 4,042.632 | 3,136.781 | 2,987.482 | 2,895.441 | 2,519.008 | 2,391.627 | 2,145.652 | 1,775.193 | 1,256.731 | 938.69 | 1,052.403 | 840.685 | 606.635 | 574.999 |
| Gross Profit Ratio
| 0.276 | 0.305 | 0.202 | 0.279 | 0.224 | 0.201 | 0.24 | 0.242 | 0.222 | 0.219 | 0.221 | 0.215 | 0.191 | 0.187 | 0.22 | 0.22 | 0.194 | 0.199 |
| Reseach & Development Expenses
| 83.45 | 77.505 | 66.06 | 85.971 | 87.36 | 85.605 | 40.772 | 38.011 | 38.76 | 58.488 | 59.09 | 52.144 | 23.711 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,023.969 | 133.723 | 132.289 | 94.395 | 80.839 | 55.744 | 55.581 | 52.65 | 49.261 | 45.192 | 42.771 | 35.582 | 28.886 | 72.676 | 70.117 | 52.743 | 44.63 | 48.084 |
| Selling & Marketing Expenses
| 23.297 | 702.8 | 683.648 | 650.196 | 545.317 | 330.659 | 290.606 | 255.044 | 229.13 | 243.412 | 250.06 | 203.19 | 173.63 | 167.325 | 153.698 | 121.288 | 104.398 | 106.616 |
| SG&A
| 4,320.6 | 836.523 | 815.937 | 744.591 | 626.156 | 386.403 | 346.187 | 307.694 | 278.391 | 288.604 | 292.831 | 238.772 | 202.516 | 240.001 | 223.816 | 174.031 | 149.027 | 154.7 |
| Other Expenses
| 40.3 | 21.9 | -45.632 | -27.397 | -20.339 | -10.79 | -17.439 | -5.784 | -9.743 | -4.844 | -18.996 | -13.473 | -3.216 | 164.294 | 182.637 | 262.376 | 144.702 | 117.988 |
| Operating Expenses
| 4,320.6 | 5,722.6 | 2,060.287 | 2,053.23 | 1,812.66 | 1,427.462 | 1,332.544 | 1,239.373 | 1,062.454 | 961.349 | 898.182 | 781.5 | 668.549 | 429.506 | 387.838 | 313.566 | 260.816 | 265.51 |
| Operating Income
| 2,650.1 | 2,567.736 | 2,883.874 | 3,881.264 | 2,134.198 | 1,660.54 | 1,654.938 | 1,166.908 | 970.396 | 1,008.54 | 866.601 | 658.784 | 325.417 | 509.184 | 664.565 | 527.119 | 345.819 | 309.488 |
| Operating Income Ratio
| 0.105 | 0.095 | 0.116 | 0.18 | 0.118 | 0.106 | 0.133 | 0.098 | 0.086 | 0.092 | 0.089 | 0.08 | 0.049 | 0.102 | 0.139 | 0.138 | 0.111 | 0.107 |
| Total Other Income Expenses Net
| -294.8 | -325.916 | -184.323 | -191.125 | -281.313 | -350.307 | -409.906 | -392.691 | -511.711 | -429.95 | -377.355 | -283.035 | -259.942 | -178.087 | -190.538 | -266.71 | -144.886 | -119.157 |
| Income Before Tax
| 2,355.3 | 2,241.8 | 2,699.551 | 3,690.139 | 1,852.885 | 1,310.233 | 1,245.032 | 1,147.731 | 952.749 | 997.197 | 847.604 | 658.784 | 322.198 | 331.097 | 474.026 | 260.409 | 200.933 | 190.331 |
| Income Before Tax Ratio
| 0.093 | 0.083 | 0.108 | 0.171 | 0.103 | 0.084 | 0.1 | 0.096 | 0.084 | 0.091 | 0.087 | 0.08 | 0.049 | 0.066 | 0.099 | 0.068 | 0.064 | 0.066 |
| Income Tax Expense
| 639.4 | 578.2 | 649.593 | 886.156 | 438.9 | 412.719 | 421.965 | 342.1 | 265.5 | 224.654 | 239.651 | 206.4 | 97.588 | 96.052 | 189.628 | 84.713 | 52.817 | 42.715 |
| Net Income
| 1,714.182 | 1,663.1 | 2,050.386 | 2,804.13 | 1,414.006 | 897.515 | 823.067 | 805.631 | 687.249 | 772.543 | 617.123 | 452.384 | 216.037 | 237.132 | 282.303 | 159.659 | 137.373 | 137.678 |
| Net Income Ratio
| 0.068 | 0.061 | 0.082 | 0.13 | 0.078 | 0.057 | 0.066 | 0.067 | 0.061 | 0.071 | 0.064 | 0.055 | 0.033 | 0.047 | 0.059 | 0.042 | 0.044 | 0.048 |
| EPS
| 18.56 | 17.96 | 22.14 | 30.09 | 15.17 | 9.51 | 8.73 | 8.37 | 7.1 | 7.98 | 6.37 | 4.67 | 2.23 | 2.32 | 2.99 | 1.71 | 1.47 | 1.47 |
| EPS Diluted
| 18.56 | 17.96 | 22.14 | 30.09 | 15.17 | 9.51 | 8.73 | 8.37 | 7.1 | 7.98 | 6.37 | 4.67 | 2.23 | 2.32 | 2.99 | 1.71 | 1.47 | 1.47 |
| EBITDA
| 3,164.6 | 3,077.9 | 3,424.384 | 4,424.766 | 2,671.472 | 2,100.297 | 2,011.36 | 1,910.339 | 1,777.558 | 1,706.349 | 1,486.207 | 1,213.42 | 808.748 | 715.987 | 857.714 | 683.752 | 495.639 | 447.029 |
| EBITDA Ratio
| 0.125 | 0.113 | 0.138 | 0.205 | 0.148 | 0.135 | 0.162 | 0.16 | 0.157 | 0.156 | 0.153 | 0.147 | 0.123 | 0.143 | 0.179 | 0.179 | 0.159 | 0.154 |